SureTrader
Interactive Brokers Advertisement
Home > Boards > Free Zone > Health and Sciences >

Biotech Values

RSS Feed
      Hide Sticky   Hide Intro
Moderator: DewDiligence Assistants: Biowatch
Search This Board: 
Last Post: 12/15/2017 6:54:32 PM - Followers: 1368 - Board type: Free - Posts Today: 0

Biotech Values is a forum for discussing 
all facets of biotech investing with an emphasis
on fundamental analysis and avoiding scams.
We generally do not discuss microcap stocks.

Calendars and Compilations
Webcasts
FDA Calendar
Recent Biotech Buyouts

Buyouts of Biotech Partners
Common Biotech-Newbie Mistakes
Biotech Holdings of Selected Institutional Investors
US Patent Expirations for Big-Selling Biologics
Biotech and Miscellaneous Acronyms

Top Twitter Feeds for Biotech Info
iHub's Greatest Hits (thru 5/09)

SureTrader
Interactive Brokers Advertisement
PostSubject
#216079  Sticky Note BLUE’s CEO sold $21.7M stock 12/13/17—one day after DewDiligence 12/15/17 04:20:37 PM
#216074  Sticky Note TRIL $150M shelf prospectus filed ronpopeil 12/15/17 03:04:03 PM
#216073  Sticky Note Re: RVNC’s valuation (updated) DewDiligence 12/15/17 02:39:23 PM
#216069  Sticky Note The ABBV/ENTA share of NRx may be the Rocky3 12/15/17 12:47:43 PM
#216062  Sticky Note A ‘Better Botox’ May Target Millennials, Men and jbog 12/15/17 11:26:15 AM
#216061  Sticky Note Any thoughts on Jim Chanos comment yesterday that flatlander_60048 12/15/17 11:26:02 AM
#216084   FIFO tax-lot provision eliminated from final US-tax bill (thankfully): DewDiligence 12/15/17 06:54:32 PM
#216083   MDGL. ...mcbio ...At end of Q3 they had mcbio 12/15/17 06:30:58 PM
#216082   Remember that CARA was added to the NBI, CHM_760 12/15/17 06:17:24 PM
#216081   What a nice Friday afternoon PR. I can't Bickema 12/15/17 04:36:42 PM
#216080   PETX -10%/AH on failed pivotal trial of ATX-016: DewDiligence 12/15/17 04:31:36 PM
#216079   BLUE’s CEO sold $21.7M stock 12/13/17—one day after DewDiligence 12/15/17 04:20:37 PM
#216078   CARA, anyone see any news or twitter feeds biotech jim 12/15/17 04:06:03 PM
#216077   "Medicare and Medicaid not paying for ineffective drugs north40000 12/15/17 03:37:21 PM
#216076   TRIL: Do you or anyone else know if they ghmm 12/15/17 03:36:48 PM
#216075   Chanos In my view these programs are probably be flatlander_60048 12/15/17 03:23:20 PM
#216074   TRIL $150M shelf prospectus filed ronpopeil 12/15/17 03:04:03 PM
#216073   Re: RVNC’s valuation (updated) DewDiligence 12/15/17 02:39:23 PM
#216072   (Revised)—RVNC’s pro forma cash balance is $292.8M. This DewDiligence 12/15/17 02:32:43 PM
#216071   (Revised)—RVNC’s fully-diluted* share count for valuation purposes is DewDiligence 12/15/17 02:20:15 PM
#216070   TEVA slides from “restructuring” CC yesterday: DewDiligence 12/15/17 01:21:50 PM
#216069   The ABBV/ENTA share of NRx may be the Rocky3 12/15/17 12:47:43 PM
#216068   TRXC - lap surgeon talks about platform usage, nowlurking 12/15/17 12:17:55 PM
#216067   Re: Chanos DewDiligence 12/15/17 12:11:05 PM
#216066   I wouldn't bet on companies that sell opioids, GrthzGd 12/15/17 12:09:02 PM
#216065   MDGL. ...mcbio ...At end of Q3 they had Whalatane 12/15/17 12:06:36 PM
#216064   If the tax plan is approved large pharma biopa 12/15/17 12:02:32 PM
#216063   ABT raises dividend for 46th consecutive year: DewDiligence 12/15/17 11:43:42 AM
#216062   A ‘Better Botox’ May Target Millennials, Men and jbog 12/15/17 11:26:15 AM
#216061   Any thoughts on Jim Chanos comment yesterday that flatlander_60048 12/15/17 11:26:02 AM
#216060   GBT sells 3.03M* shares @$38.00—a 4% discount to DewDiligence 12/15/17 11:15:52 AM
#216059   Recent Biotech Buyouts of Publicly Traded Companies DewDiligence 12/15/17 11:08:29 AM
#216058   Thanks for sharing Dew. It would make sense Bickema 12/15/17 11:08:18 AM
#216057   Genoptix acquires ROSG for $0.60/sh cash—a 5% discount DewDiligence 12/15/17 10:41:59 AM
#216056   VSTM -12% on pricing of $25M offering—although PR DewDiligence 12/15/17 10:37:17 AM
#216055   ENTA—Mavyret US scripts—week ending 12/8/17 (according to IMS)…. DewDiligence 12/15/17 10:23:25 AM
#216054   "Di-munition," a bullet with which you can hit GrthzGd 12/15/17 10:22:55 AM
#216053   Correct! What was odd was that she said DewDiligence 12/15/17 10:09:46 AM
#216052   MDGL, dimunition or diminition should be diminution? biotech jim 12/15/17 10:06:35 AM
#216051   I'll make it easy: The slip-up comes about DewDiligence 12/15/17 09:18:48 AM
#216050   Why would PFE create more competition for itself DewDiligence 12/15/17 09:16:48 AM
#216048   MDGL - Pt of this post . mcbio 12/14/17 11:44:00 PM
#216047   Dew, PFE will now presumably seek to out-license alternatepatel 12/14/17 11:27:22 PM
#216046   SAGE/MRNS—Rogerm, I partially agree with your post. SAGE Titan V 12/14/17 10:47:46 PM
#216045   MDGL> Nor will I listen to the webcast biotech jim 12/14/17 09:18:29 PM
#216044   Thx but all the FXR agonists I've looked Whalatane 12/14/17 08:36:38 PM
#216043   I'm a well-documented bear on ICPT, so we DewDiligence 12/14/17 08:22:59 PM
#216042   MDGL. Dew a question for you. Do Whalatane 12/14/17 08:16:02 PM
#216041   MDGL—I don't know of a better drug in DewDiligence 12/14/17 08:07:22 PM
#216040   Ha ...no I'm not going to listen to Whalatane 12/14/17 07:52:44 PM
#216039   MDGL quiz—On the 12/6/17 NASH webcast, Dr. Taub DewDiligence 12/14/17 07:25:00 PM
#216038   Added to my position as well. Nice rwwine 12/14/17 06:57:46 PM
#216037   > It’s curious that both CLLS and its dangerM 12/14/17 06:47:26 PM
#216036   MRK—Keytruda monotherapy in second-line gastric cancer shows non-statsig DewDiligence 12/14/17 06:08:43 PM
#216035   I’m playing vtgn ronpopeil 12/14/17 05:50:20 PM
#216034   SAGE has run several PPD & MDD trials rogerm 12/14/17 05:44:52 PM
PostSubject